Free Trial

Bolt Biotherapeutics (BOLT) Insider Trading & Ownership

Bolt Biotherapeutics logo
$0.32 +0.01 (+2.52%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$0.30 -0.02 (-6.15%)
As of 04:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bolt Biotherapeutics (NASDAQ:BOLT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2,850.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BOLT Insider Buying and Selling by Quarter

Bolt Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024Sarah NemecVPBuy2,500$0.50$1,250.00  
6/6/2024Sarah NemecVPBuy2,500$0.64$1,600.00  
(Data available from 1/1/2013 forward)

BOLT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bolt Biotherapeutics includes Edgar Engleman, Holdings A/S Novo, Sarah Nemec, Vivo Capital Viii, Llc, and William P Quinn. Learn more on insiders at BOLT.

6.10% of Bolt Biotherapeutics stock is owned by insiders. Learn more on BOLT's insider holdings.

The following insiders have purchased BOLT shares in the last 24 months: Sarah Nemec ($2,850.00), and William P Quinn ($11,233.22).

Insiders have purchased a total of 16,829 BOLT shares in the last 24 months for a total of $14,083.22 bought.

The following insiders have sold BOLT shares in the last 24 months: Edgar Engleman ($60,467.15), and Vivo Capital Viii, Llc ($64,724.00).

Insiders have sold a total of 135,333 Bolt Biotherapeutics shares in the last 24 months for a total of $125,191.15 sold.

Bolt Biotherapeutics Key Executives

  • Mr. William P. QuinnMr. William P. Quinn (Age 53)
    CEO, CFO, President, Secretary & Director
    Compensation: $610.8k
  • Mr. Grant Yonehiro C.F.A. (Age 60)
    M.B.A., Chief Operating Officer
    Compensation: $564.65k
  • Ms. Sarah Nemec (Age 48)
    VP of Finance & Principal Accounting Officer
    1 recent trades
  • Mr. Wesley Burwell
    VP & Head of Human Resources
  • Dr. Nathan Ihle Ph.D.
    Senior Vice President of Pharmaceutical Operations
  • Dr. Dawn Colburn BCOP
    Pharm.D., Senior Vice President of Clinical Development
  • Dr. Michael N. Alonso Ph.D.
    Senior Vice President of Research


This page (NASDAQ:BOLT) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners